Pharmaceutical Licensing Trends: What Products Are Labs Looking for in LATAM Today
Pharmaceutical Licensing Trends: What Products Are Labs Looking for in LATAM Today
The pharmaceutical market in Latin America is evolving rapidly, driven by epidemiological changes, cost pressures, and the need for differentiation.
In this context, licensing has become a key tool for laboratories and distributors to remain competitive.
🔍 What are laboratories in LATAM looking for today?
Based on market analysis and ongoing interactions with multiple companies across the region, these are the main trends:
High-value molecules in oncology
There is strong demand for:
- Targeted therapies
- Oral oncology treatments
- Clinically differentiated products
Molecules such as tyrosine kinase inhibitors (TKIs) like dasatinib, ibrutinib, acalabrutinib, and zanobrutinib, as well as personalized therapies, are at the forefront of expansion.
🧠 Growth in Central Nervous System (CNS)
The rise in neurological and psychiatric disorders has driven demand for:
- Antiepileptics
- Innovative antidepressants
- Treatments for multiple sclerosis
🩺 Diabetes and metabolic diseases
With the increasing prevalence of diabetes in the region, laboratories are seeking:
- New combinations
- Molecules with cardiovascular benefits
- Differentiated formulations
🌿 Boom in supplements and OTC products
Consumers are shifting toward preventive solutions, leading to:
- Growth in the supplements market
- Interest in natural and wellness products
- Expansion of OTC lines
🔄 Repositioning of known molecules
Not everything is radical innovation. Many companies are focusing on:
- New indications
- New formats such as patches, liquid stick packs, and sachets
- Commercial differentiation strategies
⚙️ Key factors to close a successful deal
Beyond the product itself, laboratories evaluate:
- Being the first generic available for a patented product
- Dossier quality (full CTD, bioequivalence, stability in Zone IVb)
- Regulatory status in other markets
- Commercial terms (MOQs adaptable to different markets, pricing, payment terms)
- Ongoing communication with the manufacturer
🤝 INPHORIA’s role in this ecosystem
INPHORIA facilitates connections between global manufacturers and companies in LATAM, ensuring that every opportunity includes:
- Fast response times
- Favorable commercial conditions for all parties
- Support in reviewing regulatory and patent documentation
- Clear business structures
We act as a strategic bridge to accelerate access to new products in the region.
📊 Conclusion
Pharmaceutical licensing trends in LATAM show a clear focus on high-value products, differentiation, and speed of execution.
Companies that anticipate these trends and partner with strategic allies will be the ones leading the market in the coming years.
👉 Want to discover which products fit your portfolio?
Write to us—we’re here to help.
